Skip to content

13F-HR filed by Soleus Capital Management, L.P.

Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 72 holding rows worth $640,262,000.

Accession
0001802630-22-000007
Filed
2022-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 74 entries on the cover page, a total value of $640,262,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $641,027,000 with VALUE read as thousands by filing date, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNITED THERAPEUTICS CORP DEL COM91307C102Stock295,541$69,641,000thousands by filing date
SKINHEALTH SYSTEMS INC88331L108COM CL A3,276,037$42,130,000thousands by filing date
ORGANOGENESIS HOLDINGS INC68621F102COMMON STOCK5,286,167$25,796,000thousands by filing date
Surmodics Inc868873100Common Stock661,004$24,609,000thousands by filing date
EDAP TMS S A268311107SPONSORED ADR3,284,189$22,332,000thousands by filing date
IRADIMED CORP46266A109COMMON STOCK620,765$21,069,000thousands by filing date
CVS Health Corporation126650100COM219,400$20,330,000thousands by filing date
THERATECHNOLOGIES INC COM88338H100COM7,822,412$17,757,000thousands by filing date
SKINHEALTH SYSTEMS INC88331L108COM CL A1,300,000$16,718,000thousands by filing datecall
ARCELLX INC COMMON STOCK03940C100Stock909,739$16,448,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock88,950$16,248,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock214,482$14,083,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW4,168,799$13,132,000thousands by filing date
ANAPTYSBIO INC032724106COM643,575$13,065,000thousands by filing date
ANGIODYNAMICS INC03475V101COM670,000$12,965,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM815,740$12,660,000thousands by filing date
NURIX THERAPEUTICS INC67080M103COMMON STOCK994,492$12,600,000thousands by filing date
APOLLO ENDOSURGERY INC03767D108COM3,268,948$11,932,000thousands by filing date
NEUROPACE INC641288105COMMON STOCK2,334,003$11,553,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR169,696$11,212,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW183,800$10,879,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM841,018$9,731,000thousands by filing date
CUTERA INC232109108COM257,600$9,660,000thousands by filing date
EVOLUS INC30052C107COM810,676$9,404,000thousands by filing date
BIOATLA INC09077B104COM3,262,703$9,299,000thousands by filing date
IVERIC BIO INC46583P102COM914,346$8,796,000thousands by filing date
PENUMBRA INC COM70975L107Stock68,800$8,567,000thousands by filing date
VAXCYTE INC COM92243G108Stock370,650$8,065,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM719,600$7,944,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM4,134,868$7,732,000thousands by filing date
STERIS PLC SHS USDG8473T100Stock37,310$7,691,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM258,100$7,464,000thousands by filing date
CVRX INC126638105COMMON STOCK1,059,040$6,365,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS77,842$6,209,000thousands by filing date
INCYTE CORP COM45337C102Stock79,700$6,055,000thousands by filing date
TRANSMEDICS GROUP INC89377M109COM184,455$5,801,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM846,000$5,330,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock75,094$5,326,000thousands by filing date
INARI MED INC45332Y109COM72,298$4,916,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM194,400$4,817,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM100,000$4,727,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock119,000$4,687,000thousands by filing date
NATERA INC COM632307104Stock131,873$4,674,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM318,100$4,377,000thousands by filing date
ESTABLISHMENT LABS HOLDINGSG31249108COMMON STOCK78,400$4,263,000thousands by filing date
INMODE LTD SHSM5425M103Stock187,449$4,201,000thousands by filing date
PLIANT THERAPEUTICS INC729139105COM490,000$3,925,000thousands by filing date
CHEMOCENTRYX INC16383L106COM154,400$3,826,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM196,018$3,815,000thousands by filing date
CELCUITY INC15102K100COM418,912$3,812,000thousands by filing date
LANTHEUS HLDGS INC516544103COM55,222$3,646,000thousands by filing date
DEXCOM INC COM252131107Stock47,236$3,520,000thousands by filing date
LYRA THERAPEUTICS INC55234L105COM592,417$3,347,000thousands by filing date
FIBROGEN INC31572Q808COM302,226$3,192,000thousands by filing date
IO BIOTECH INC449778109COM655,404$3,061,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock20,100$2,932,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock75,000$2,282,000thousands by filing date
C4 THERAPEUTICS INC12529R107COM STK282,640$2,131,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM252,000$2,084,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock136,182$2,060,000thousands by filing date
VERASTEM INC92337C104COM1,644,500$1,908,000thousands by filing date
PEPGEN INC COM713317105Stock175,000$1,738,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM88,000$1,539,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock22,000$1,337,000thousands by filing date
Xilio Therapeutics Inc.98422T100COM453,660$1,325,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM95,485$1,224,000thousands by filing date
BRIDGEBIO PHARMA INC10806XAB8NOTE 2.500% 3/11,950,000$1,068,000thousands by filing dateprincipal
OUTSET MEDICAL INC690145107COM69,200$1,028,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS13,275$923,000thousands by filing date
IMMUNIC INC4525EP101COM240,000$833,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM825,000$726,000thousands by filing date
DA32 LIFE SCNCE TEC ACQSTN C23312M106CLASS A COM50,000$485,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001802630-22-000007this filing2022-08-15acceptance time not in the bulk data set